Retaane News
Most Popular Retaane Story
Alcon faces setback on experimental AMD therapy
Shares of Alcon slipped this morning after the eye care giant announced that the FDA would require another trial of its experimental therapy for wet, age-related macular degeneration. Researchers... Read more...
Latest Headlines
- September 25, 2007
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
